Legionnaires' disease after immunosuppression; response to erythromycin.
D004917:Erythromycin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007877:Legionnaires' Disease / Q000188:drug therapy / Q000209:etiology*; D008875:Middle Aged
D004917:Erythromycin